415 related articles for article (PubMed ID: 21048331)
1. Chitosan nanoparticles: a promising system in novel drug delivery.
Nagpal K; Singh SK; Mishra DN
Chem Pharm Bull (Tokyo); 2010 Nov; 58(11):1423-30. PubMed ID: 21048331
[TBL] [Abstract][Full Text] [Related]
2. Facile preparation of well-defined near-monodisperse chitosan/sodium alginate polyelectrolyte complex nanoparticles (CS/SAL NPs) via ionotropic gelification: a suitable technique for drug delivery systems.
Liu P; Zhao X
Biotechnol J; 2013 Jul; 8(7):847-54. PubMed ID: 23625874
[TBL] [Abstract][Full Text] [Related]
3. Advances and Potential Applications of Chitosan Nanoparticles as a Delivery Carrier for the Mucosal Immunity of Vaccine.
Li D; Fu D; Kang H; Rong G; Jin Z; Wang X; Zhao K
Curr Drug Deliv; 2017; 14(1):27-35. PubMed ID: 27494157
[TBL] [Abstract][Full Text] [Related]
4. Chitosan Nanoparticles as a Novel Drug Delivery System: A Review Article.
Matalqah SM; Aiedeh K; Mhaidat NM; Alzoubi KH; Bustanji Y; Hamad I
Curr Drug Targets; 2020; 21(15):1613-1624. PubMed ID: 32651965
[TBL] [Abstract][Full Text] [Related]
5. Recent advances of chitosan nanoparticles as drug carriers.
Wang JJ; Zeng ZW; Xiao RZ; Xie T; Zhou GL; Zhan XR; Wang SL
Int J Nanomedicine; 2011; 6():765-74. PubMed ID: 21589644
[TBL] [Abstract][Full Text] [Related]
6. Chitosan-based nanoparticles as drug delivery systems: a review on two decades of research.
Naskar S; Koutsu K; Sharma S
J Drug Target; 2019 Apr; 27(4):379-393. PubMed ID: 30103626
[TBL] [Abstract][Full Text] [Related]
7. Nanoparticles for ocular drug delivery: modified and non-modified chitosan as a promising biocompatible carrier.
Pontillo ARN; Detsi A
Nanomedicine (Lond); 2019 Jul; 14(14):1889-1909. PubMed ID: 31274373
[TBL] [Abstract][Full Text] [Related]
8. Chitosan-based nanoparticles for tumor-targeted drug delivery.
Prabaharan M
Int J Biol Macromol; 2015 Jan; 72():1313-22. PubMed ID: 25450550
[TBL] [Abstract][Full Text] [Related]
9. Nasal delivery of insulin using novel chitosan based formulations: a comparative study in two animal models between simple chitosan formulations and chitosan nanoparticles.
Dyer AM; Hinchcliffe M; Watts P; Castile J; Jabbal-Gill I; Nankervis R; Smith A; Illum L
Pharm Res; 2002 Jul; 19(7):998-1008. PubMed ID: 12180553
[TBL] [Abstract][Full Text] [Related]
10. Advances in preparation and characterization of chitosan nanoparticles for therapeutics.
Chandra Hembram K; Prabha S; Chandra R; Ahmed B; Nimesh S
Artif Cells Nanomed Biotechnol; 2016; 44(1):305-14. PubMed ID: 25137489
[TBL] [Abstract][Full Text] [Related]
11. Preparation of collagen peptide functionalized chitosan nanoparticles by ionic gelation method: An effective carrier system for encapsulation and release of doxorubicin for cancer drug delivery.
Anandhakumar S; Krishnamoorthy G; Ramkumar KM; Raichur AM
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):378-385. PubMed ID: 27770906
[TBL] [Abstract][Full Text] [Related]
12. A Review of the Preparation, Characterization, and Applications of Chitosan Nanoparticles in Nanomedicine.
Jha R; Mayanovic RA
Nanomaterials (Basel); 2023 Apr; 13(8):. PubMed ID: 37110887
[TBL] [Abstract][Full Text] [Related]
13. Solid lipid nanoparticles for oral drug delivery: chitosan coating improves stability, controlled delivery, mucoadhesion and cellular uptake.
Luo Y; Teng Z; Li Y; Wang Q
Carbohydr Polym; 2015 May; 122():221-9. PubMed ID: 25817662
[TBL] [Abstract][Full Text] [Related]
14. New drug delivery systems based on chitosan.
Paños I; Acosta N; Heras A
Curr Drug Discov Technol; 2008 Dec; 5(4):333-41. PubMed ID: 19075614
[TBL] [Abstract][Full Text] [Related]
15. Chitosan nanoparticles for plasmid DNA delivery: effect of chitosan molecular structure on formulation and release characteristics.
Bozkir A; Saka OM
Drug Deliv; 2004; 11(2):107-12. PubMed ID: 15200009
[TBL] [Abstract][Full Text] [Related]
16. Self-assembled chitosan-insulin oral nanoparticles - A critical perspective review.
Chellathurai MS; Yong CL; Sofian ZM; Sahudin S; Hasim NBM; Mahmood S
Int J Biol Macromol; 2023 Jul; 243():125125. PubMed ID: 37263321
[TBL] [Abstract][Full Text] [Related]
17. Chitosan/sulfobutylether-β-cyclodextrin nanoparticles as a potential approach for ocular drug delivery.
Mahmoud AA; El-Feky GS; Kamel R; Awad GE
Int J Pharm; 2011 Jul; 413(1-2):229-36. PubMed ID: 21540097
[TBL] [Abstract][Full Text] [Related]
18. Potential Antimicrobial Applications of Chitosan Nanoparticles (ChNP).
Rozman NAS; Tong WY; Leong CR; Tan WN; Hasanolbasori MA; Abdullah SZ
J Microbiol Biotechnol; 2019 Jul; 29(7):1009-1013. PubMed ID: 31288302
[TBL] [Abstract][Full Text] [Related]
19. Chitosan Nanoparticles-Insight into Properties, Functionalization and Applications in Drug Delivery and Theranostics.
Jhaveri J; Raichura Z; Khan T; Momin M; Omri A
Molecules; 2021 Jan; 26(2):. PubMed ID: 33430478
[TBL] [Abstract][Full Text] [Related]
20. Design, characterisation, and bioefficiency of insulin-chitosan nanoparticles after stabilisation by freeze-drying or cross-linking.
Diop M; Auberval N; Viciglio A; Langlois A; Bietiger W; Mura C; Peronet C; Bekel A; Julien David D; Zhao M; Pinget M; Jeandidier N; Vauthier C; Marchioni E; Frere Y; Sigrist S
Int J Pharm; 2015 Aug; 491(1-2):402-8. PubMed ID: 26049075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
